4月25日，春立医疗盘中上涨5.44%，截至09:54，报14.72元/股，成交5895.17万元，换手率5.03%，总市值56.46亿元。
资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通州经济开发区南区鑫觅西二路10号，公司主要致力于高端骨科医疗器械的开发和研究，产品多元化且遍布全球50多个国家，主要涵盖关节类、脊柱类、运动医学类、创伤类等全系列骨科产品，同时也在尝试拓展齿科、富血小板血浆制备系统、骨科手术机器人等领域。公司已经获得了124项医疗器械注册证及备案凭证，并且已独立研发多款在国内市场上享有独特优势和领先地位的产品，进一步提升了公司的核心竞争力和行业影响力，有力地推动了我国关节领域自主创新的水平。
截至9月30日，春立医疗股东户数7998，人均流通股2.18万股。
2024年1月-9月，春立医疗实现营业收入5.08亿元，同比减少35.84%；归属净利润6115.14万元，同比减少66.14%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.